Leo Pharmaceuticals Inc is a global leader in medical dermatology, dedicated to advancing the standard of care for people with skin conditions. With a rich legacy dating back to 1908 and headquartered in Denmark, they are majority owned by the LEO Foundation and have a strong focus on research and development to provide innovative treatment options. Committed to responsible and ethical business practices, Leo Pharmaceuticals aims to make a true difference in the lives of individuals living with skin diseases through strategic partnerships and alliances.
Through their established portfolio and new treatment options, Leo Pharmaceuticals helps people achieve healthy skin by combining their expertise in dermatology with a commitment to compliance and sustainability. Their mission is to empower patients, ensure sustainable operations, and promote diversity and inclusion in the healthcare industry. With a vision to become a more sustainable company and deliver a financial turnaround by 2023, Leo Pharmaceuticals is dedicated to pioneering together with their team, patients, and partners to continuously improve and extend possibilities in medical dermatology.
Generated from the website